Trial Details

COMPLETED
Basic Information
Clinical ID c4227
Identifier NCT00813098
Trial Title Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Irritable Bowel Syndrome
Interventions DRUG: LX1031 High Dose|DRUG: LX1031 Low Dose|DRUG: Placebo
Participant Information
Sponsor Lexicon Pharmaceuticals
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2008-12
Primary Completion Date 2009-07
Completion Date 2010-08